BTV Business Television announces its upcoming broadcast on FOX Business News featuring eight emerging companies in the mining and biotech sectors. Among them, Lexaria Bioscience (NASDAQ: LEXX) is highlighted for its DehydraTECH™ technology, which enhances oral drug bioavailability and efficacy, particularly in the GLP-1 market. The technology promises improved absorption, extended drug retention, and reduced side effects. The broadcast will air on December 1, 2024, showcasing various companies’ developments in gold mining, metals, and pharmaceutical innovation.
BTV Business Television annuncia la sua prossima trasmissione su FOX Business News che presenterà otto aziende emergenti nei settori minerario e biotecnologico. Tra queste, Lexaria Bioscience (NASDAQ: LEXX) è messa in evidenza per la sua tecnologia DehydraTECH™, che migliora la biodisponibilità e l’efficacia dei farmaci orali, in particolare nel mercato dei GLP-1. Questa tecnologia promette un’assorbimento migliorato, una maggiore ritenzione del farmaco e effetti collaterali ridotti. La trasmissione andrà in onda il 1° dicembre 2024, mostrando gli sviluppi delle varie aziende nell’estrazione dell’oro, nei metalli e nell’innovazione farmaceutica.
BTV Business Television anuncia su próxima transmisión en FOX Business News que presentará ocho empresas emergentes en los sectores minero y biotecnológico. Entre ellas, Lexaria Bioscience (NASDAQ: LEXX) se destaca por su tecnología DehydraTECH™, que mejora la biodisponibilidad y eficacia de los medicamentos orales, particularmente en el mercado de GLP-1. Esta tecnología promete una mejor absorción, una mayor retención del fármaco y efectos secundarios reducidos. La transmisión se emitirá el 1 de diciembre de 2024, mostrando los desarrollos de varias empresas en la minería de oro, metales e innovación farmacéutica.
BTV 비즈니스 텔레비전은 FOX 비즈니스 뉴스에서 금속 및 생명공학 분야의 신생 기업 8개를 소개하는 방송을 곧 진행한다고 발표했습니다. 그 중 Lexaria Bioscience (NASDAQ: LEXX)는 GLP-1 시장에서 경구 약물의 생체이용률과 효능을 향상시키는 DehydraTECH™ 기술로 주목받고 있습니다. 이 기술은 흡수를 개선하고 약물의 지속 시간을 연장하며 부작용을 줄일 것으로 기대됩니다. 방송은 2024년 12월 1일에 방영되며, 금 채굴, 금속 및 제약 혁신 분야의 다양한 회사 발전 상황을 보여줄 것입니다.
BTV Business Television annonce sa prochaine diffusion sur FOX Business News mettant en avant huit entreprises émergentes dans les secteurs minier et biotechnologique. Parmi elles, Lexaria Bioscience (NASDAQ: LEXX) est mise en lumière pour sa technologie DehydraTECH™, qui améliore la biodisponibilité et l’efficacité des médicaments oraux, en particulier sur le marché des GLP-1. Cette technologie promet une meilleure absorption, une rétention prolongée des médicaments et une réduction des effets secondaires. La diffusion aura lieu le 1er décembre 2024, présentant les développements des différentes entreprises dans l’extraction de l’or, des métaux et de l’innovation pharmaceutique.
BTV Business Television kündigt seine bevorstehende Ausstrahlung auf FOX Business News an, in der acht aufstrebende Unternehmen aus den Bereichen Bergbau und Biotechnologie vorgestellt werden. Unter ihnen wird Lexaria Bioscience (NASDAQ: LEXX) für ihre DehydraTECH™-Technologie hervorgehoben, die die orale Bioverfügbarkeit und Wirksamkeit von Medikamenten erhöht, insbesondere im GLP-1-Markt. Die Technologie verspricht eine verbesserte Absorption, verlängerte Medikamentenretention und verringerte Nebenwirkungen. Die Ausstrahlung wird am 1. Dezember 2024 stattfinden und verschiedene Unternehmensentwicklungen im Goldbergbau, in der Metallverarbeitung und in der pharmazeutischen Innovation präsentieren.
Positive
- DehydraTECH technology shows potential in the growing GLP-1 market
- Technology demonstrates improved drug absorption and retention
- Technology reportedly reduces drug side effects
Vancouver, British Columbia–(Newsfile Corp. – November 30, 2024) – On FOX Business News broadcast on Sunday, Dec 1, 2024 – BTV Business Television interviews emerging companies in the markets including:
Contango ORE, Inc. (NYSE American: CTGO) – Redefining modern gold mining, Contango ORE has achieved remarkable efficiency through its hybrid royalty model and strategic partnerships. Leveraging existing infrastructure to minimize environmental impact, the company accelerates production timelines and optimizes costs.
First Nordic Metals (TSX: FNM) (OTCQB: FNMCF) – Backed by a recent
Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) – Champion Iron continues to lead the way in sustainable mining with its high-purity iron ore product, vital for decarbonizing the steel industry. The company capped its 2024 financial year with a strong balance sheet, allowing for the continuation of its growth projects and capital return strategy, including a 7th consecutive semi-annual dividend.
Prime Mining Corp. (TSX: PRYM) (OTCQX: PRMNF) – Focused on resource expansion and technical de-risking, Prime Mining is poised to support the growing demand for sustainable and scalable mining solutions, solidifying its position in the global precious metals sector.
Lexaria Bioscience Corp. (NASDAQ: LEXX) – Pioneering advancements in pharmaceutical delivery, Lexaria’s patented DehydraTECH™ technology significantly enhances the bioavailability and efficacy of oral drugs. With applications in the rapidly expanding GLP-1 market, this breakthrough technology offers improved absorption, extended drug retention, and reduced side effects.
Osisko Development Corp. (TSXV: ODV) (NYSE: ODV) – Having received construction permits at its flagship Cariboo Gold project in BC, Canada, which hosts 2.03 million ounces of gold in the probable reserves category, Osisko is poised for a major transformation. With grid access to clean hydroelectric energy and a strong emphasis on responsible mine development, commitment to regional job creation and environmental stewardship, Osisko is focused on redefining mining for a better future.
West Red Lake Gold Mines Ltd. (TSXV: WRLG) – is set to restart gold production by mid-2025, leveraging its strong infrastructure and permits in a prolific Canadian mining district. With an indicated resource of 1.7 million ounces of gold and an additional 0.4 million ounces in the inferred category, this company is poised to unlock value and capitalize on a high gold market.
Surge Battery Metals Inc. (TSXV: NILI) (OTCQB: NILIF) – Positioned at the forefront of the energy transition, Surge is driving innovation in lithium exploration with its flagship US-based lithium clay deposit. As the largest resource of its kind in the US, this project underscores the company’s pivotal role in advancing the domestic supply chain for critical minerals, meeting the rising demand for renewable energy technologies and electric vehicles.
About BTV – Business Television:
On air for 25+ years, BTV – Business Television, a half-hour investment TV show, delivers up-and-coming companies and investment opportunities. With Hosts, Taylor Thoen and Jessica Katrichak, BTV features stock market analysts, experts and on location interviews with emerging company executives.
Tune into BTV and: Discover Investment Opportunities.
TV BROADCAST NETWORKS and TIMES:
FOX Business News US: Sunday, Dec 1st @ 5:00pm ET.
Suggest a Company to Feature!
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232021
FAQ
What is Lexaria Bioscience’s (LEXX) main technology featured in the December 2024 BTV broadcast?
Lexaria’s DehydraTECH™ technology, which enhances the bioavailability and efficacy of oral drugs, improving absorption and reducing side effects.
What market is Lexaria Bioscience (LEXX) targeting with its DehydraTECH technology?
Lexaria is targeting the GLP-1 market with its DehydraTECH technology for improved drug delivery.
When will the BTV feature about Lexaria Bioscience (LEXX) air on FOX Business News?
The BTV feature will air on FOX Business News on Sunday, December 1, 2024.
